- Updated: Sanofi, Arbutus file separate suits against mRNA vaccine makers over LNP tech patentsSanofi and Arbutus are each going to court over alleged violations of their respective mRNA delivery patents, adding to a growing list of companies making similar complaints. The French pharma is…Endpoints · 8d ago↗ source
- STAT+: Eli Lilly to acquire psychedelics-focused biotech AtaiBeckleyEli Lilly is buying the psychedelics-focused biotech AtaiBeckley for $2.8 billion upfront, a move that will expand its neuroscience pipeline.STAT · 8d ago↗ source
- Lilly bets $2.8B upfront on psychedelics in deal to buy AtaiBeckleyEli Lilly said on Thursday it will buy psychedelic drug developer AtaiBeckley for $2.8 billion upfront, in a move that further spotlights big pharma’s increasing interest in the space after years o…